Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001369568

SEC filings (opens in a new tab)

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of CPRX: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	139	2	144	+7
Shares	65.5M	13.6K	65.2M	−306.2K (−0.5%)
Value	$376.6M	$79.0K	$345.1M	−$31.3M (−8.3%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CPRX in Q3 2021
Institution	Shares	Value	% of portfolio
Aviva PLC	326,385	$1.73M	0.01%
Cornercap Investment Counsel Inc	216,144	$1.15M	0.13%
Fisher Asset Management, LLC	201,801	$1.07M	0.00%
SEI Investments Co	173,844	$921.0K	0.00%
SummerHaven Investment Management, LLC	151,384	$802.0K	0.47%
SG Americas Securities, LLC	90,273	$478.0K	0.00%
Ameriprise Financial Inc	61,027	$324.0K	0.00%
Renaissance Technologies LLC	52,238	$277.0K	0.00%
HRT Financial LP	33,380	$176.0K	0.00%
Arrowstreet Capital, Limited Partnership	30,800	$163.0K	0.00%
Two Sigma Securities, LLC	25,664	$136.0K	0.03%
Glenmede Trust Co NA	22,301	$117.0K	0.00%
LPL Financial LLC	20,073	$106.0K	0.00%
Pictet Asset Management SA	12,800	$68.0K	0.00%
Centiva Capital, LP	11,520	$62.0K	0.01%
E Fund Management Co., Ltd.	10,838	$57.0K	0.00%
Lazard Asset Management LLC	8,815	$46.0K	0.00%
Point72 Hong Kong Ltd	3,219	$17.0K	0.00%
Anfield Capital Management, LLC	125	$1.00K	0.00%
Northwestern Mutual Wealth Management Co	1	$0	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	45	$0	0.00%
Delos Wealth Advisors, LLC	1	$0	0.00%

Sold out (15)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of CPRX in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Acuta Capital Partners, LLC	329,134	$1.89M
Hancock Whitney Corp	238,281	$1.37M
Bridgeway Capital Management, LLC	83,800	$482.0K
Jump Financial, LLC	37,983	$219.0K
Maverick Capital LtdSuperinvestorMaverick Capital	35,869	$206.0K
Ergoteles LLC	33,700	$194.0K
Belvedere Trading LLC	28,488	$160.0K
Bridgefront Capital, LLC	27,460	$158.0K
Gsa Capital Partners LLP	23,855	$137.0K
HighTower Advisors, LLC	22,751	$132.0K
Brookstone Capital Management	16,472	$91.0K
Virtu Financial LLC	13,295	$76.0K
Principal Financial Group Inc	11,205	$64.0K
Pinz Capital Management, LP	3,900	$22.0K
Panagora Asset Management Inc	1,780	$10.0K

Not filed for Q3 2021 yet (2)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CPRX in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	12,800	$74.0K
CWM, LLC	790	$5.00K